[HTML][HTML] Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3–dependent signal transduction by phosphorylating human retinoid X receptor α
Human retinoid X receptor α (hRXRα) is a member of the nuclear receptor family of
transcriptional regulators. It regulates transcription through its association with several
heterodimeric partners, including the vitamin D3 receptor (VDR). Signaling through the VDR
is essential for normal calcium homeostasis and has been shown to inhibit the proliferation
of cancer cells derived from a number of tissues. Here we show that phosphorylation of
hRXRα in ras-transformed human keratinocytes through the activated Ras–Raf–mitogen …
transcriptional regulators. It regulates transcription through its association with several
heterodimeric partners, including the vitamin D3 receptor (VDR). Signaling through the VDR
is essential for normal calcium homeostasis and has been shown to inhibit the proliferation
of cancer cells derived from a number of tissues. Here we show that phosphorylation of
hRXRα in ras-transformed human keratinocytes through the activated Ras–Raf–mitogen …
Human retinoid X receptor α (hRXRα) is a member of the nuclear receptor family of transcriptional regulators. It regulates transcription through its association with several heterodimeric partners, including the vitamin D3 receptor (VDR). Signaling through the VDR is essential for normal calcium homeostasis and has been shown to inhibit the proliferation of cancer cells derived from a number of tissues. Here we show that phosphorylation of hRXRα in ras-transformed human keratinocytes through the activated Ras–Raf–mitogen-activated protein kinase (Ras-Raf-MAP kinase) pathway results in attenuated transactivation by the VDR and resistance to the growth inhibitory action of 1,25 dihydroxyvitamin D3 [1,25(OH)2D3] and RXR-specific agonist LG1069 (4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl) ethenyl]-benzoic acid). Phosphorylation of hRXRα occurs at serine 260, a consensus MAP kinase site. Inhibition of MAP kinase activity or point mutagenesis of serine 260 of hRXRα reverses the observed resistance to 1,25(OH)2D3 and LG1069. Thus, hRXRα is a downstream target of MAP kinase, and its phosphorylation may play an important role in malignant transformation.
J. Clin. Invest. 103:1729–1735 (1999).
The Journal of Clinical Investigation